newsfilter
← Latest News
Business Wire·

enGene to Participate in Upcoming Investor Conferences

enGene Holdings Inc. (NASDAQ:ENGN), a clinical-stage, non-viral genetic medicines company, today announced that management will present at upcoming investor conferences in May 2025. Details of the conferences are